Showing results (4061-4070 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|March 1, 2012
Mucin-based targeted pancreatic cancer therapyMaria P Torres, Subhankar Chakraborty, Joshua Souchek, et al.Current Pharmaceutical Design|March 1, 2012
Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancerHan Liu, Qingyong Ma, Qinhong Xu, et al.Current Pharmaceutical Design|March 1, 2012
Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatmentXuqi Li, Qingyong Ma, Qinhong Xu, et al.Current Pharmaceutical Design|March 3, 2012
Heterocyclic dications as a new class of telomeric G-quadruplex targeting agentsRupesh Nanjunda, Caterina Musetti, Arvind Kumar, et al.Current Pharmaceutical Design|November 15, 2011
L-Dopa prodrugs: an overview of trends for improving Parkinson's disease treatmentAntonio Di Stefano, Piera Sozio, Laura Serafina Cerasa, et al.Current Pharmaceutical Design|November 15, 2011
Recent advances in the design and synthesis of prednisolone and methylprednisolone conjugatesEliska Bílková, Ale Imramovský, Milos SedlákCurrent Pharmaceutical Design|November 15, 2011
Chitosan derivatives with antimicrobial, antitumour and antioxidant activities--a reviewVinsová Jarmila, Eva VavríkováCurrent Pharmaceutical Design|November 15, 2011
Is bilirubin a marker of vascular disease and/or cancer and is it a potential therapeutic target?Lars H Breimer, Dimitri P MikhailidisCurrent Pharmaceutical Design|November 15, 2011
Evaluation of the possible contribution of antioxidants administration in metabolic syndromeMohamed Haidara, Dimitri P Mikhailidis, Hanaa Z Yassin, et al.Current Pharmaceutical Design|December 23, 2016
Endothelial Progenitor Cells as a Therapeutic Approach for Intracerebral HemorrhageJuan Pías-Peleteiro, Francisco Campos, María Perez-Mato, et al.Pageof 1,008